PLGA-PEG-PLGA (1500-1500-1500) (LA/GA 15:1)
Product Specifications
UNSPSC Description
PLGA-PEG-PLGA (1500-1500-1500) (LA/GA 15:1) is a matrix materia, with lactic acid (LA)：glycolic acid (GA) = 15:1, that acts as anti-cancer drug delivery. PLGA-PEG-PLGA (1500-1500-1500) (LA/GA 15:1) can improve a drug's bioavailability, efficacy, water solubility, drug encapsulation efficiency, sustained drug release, and to minimize undesirable toxicity[1].
Target Antigen
Others
Type
Reference compound
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
cancer
Assay Protocol
https://www.medchemexpress.com/plga-peg-plga-1500-1500-1500-la-ga-15-1.html
Solubility
10 mM in DMSO
Smiles
[H]OC(C)C(OCC(OCCOC(C(C)OC(CO[H])=O)=O)=O)=O.[x].[y].[m].[x].[y].[n].[m]
Molecular Weight
Average Mn (1500-1500-1500)
References & Citations
[1]Xiufen Chen, et al. PLGA-PEG-PLGA triblock copolymeric micelles as oral drug delivery system: In vitro drug release and in vivo pharmacokinetics assessment. J Colloid Interface Sci. 2017 Mar 15:490:542-552.|[2]Yuan Gao, et al. A thermo-sensitive PLGA-PEG-PLGA hydrogel for sustained release of docetaxel. J Drug Target. 2011 Aug;19(7):516-27.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-156829A/PLGA-PEG-PLGA-1500-1500-1500-LA-GA-15-1-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-156829A/
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
